Exact Sciences diskutieren
Exact Sciences
WKN: 590273 / Symbol: EXAS / Name: EXACT Sci / Aktie / Biotechnologie & medizinische Forschung / Large Cap /
87,77 €
0,25 %
Exact Sciences (NASDAQ:EXAS) had its price target raised by analysts at Guggenheim from $70.00 to $75.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences (NASDAQ:EXAS) had its price target raised by analysts at Benchmark Co. from $60.00 to $75.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences (NASDAQ:EXAS) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for EXAS provided by MarketBeat
Exact Sciences (NASDAQ:EXAS) was given a new $88.00 price target on by analysts at Robert W. Baird. They now have an "outperform" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences (NASDAQ:EXAS) had its price target raised by analysts at TD Cowen from $74.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences (NASDAQ:EXAS) had its price target raised by analysts at Wells Fargo & Company from $68.00 to $85.00. They now have an "overweight" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences (NASDAQ:EXAS) had its price target raised by analysts at Piper Sandler from $70.00 to $80.00. They now have an "overweight" rating on the stock.
Ratings data for EXAS provided by MarketBeat
Exact Sciences (NASDAQ:EXAS) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Ratings data for EXAS provided by MarketBeat
Neueste Beiträge
UBS_Group_AG in Cabot Corp. diskutieren